WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc. scores highest on Nitro (86) and lowest on Price (15). Its PosiPenta is 53.11 out of 100, around the middle of similar companies.
On the Penta Grid this week, WuXi Biologics (Cayman) Inc. is Grid #3 of 7 in the Healthcare sector in China, and Grid #21 of 58 in China.
Compared with similar companies in the Healthcare sector in China.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| WuXi Biologics (Cayman) Inc. | 53.11 | 15 | 58 | 86 | 68 | 38 |
| Hansoh Pharmaceutical Group Company Limited | 47.56 | 12 | 28 | 59 | 76 | 61 |
| Innovent Biologics, Inc. | 48.08 | 4 | 58 | 78 | 58 | 43 |
| JD Health International Inc. | 48.56 | 43 | 59 | 35 | 67 | 38 |
| CSPC Pharmaceutical Group Limited | 54.87 | 46 | 13 | 81 | 85 | 49 |
| WuXi AppTec Co., Ltd. | 60.95 | 13 | 69 | 91 | 81 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 36.24 |
| P/B ratio | 3.58 |
EEarnings
| Trailing EPS | ₹16.07 |
| Forward EPS | ₹26.34 |
NNitro
| Price | 582.36 |
| 52-week high | 700.76 |
| 52-week low | 344.10 |
| Fall from 52-week high | 16.9% |
TTorque
| Return on equity (ROE) | 11.38% |
| Debt-to-equity | 0.05 |
AAnchor
| Beta (price swings) | 0.59 |
| Market cap | ₹2,39,717 Cr |
| Insider holding | 10.11% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is WuXi Biologics (Cayman) Inc.'s PosiPenta score?
WuXi Biologics (Cayman) Inc.'s PosiPenta is 53.11 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does WuXi Biologics (Cayman) Inc. stand on the Penta Grid?
On the Penta Grid this week, WuXi Biologics (Cayman) Inc. is Grid #3 of 7 in the Healthcare sector in China, and Grid #21 of 58 in China.
Which PosiPenta pillar is strongest for WuXi Biologics (Cayman) Inc.?
Nitro (momentum), with a score of 86 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for WuXi Biologics (Cayman) Inc.?
Price (valuation), with a score of 15 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.